Search

Searching with a thematic focus on Health systems, HIV and AIDS treatment and care, HIV and AIDS

Showing 51-60 of 107 results

Pages

• Document

  Leveraging the private sector for public health objectives: a briefing paper for DFID on technology transfer in the pharmaceuticals sector

  Department for International Development Health Systems Resource Centre, 2004

  This HSRC study maps a variety of Technology Transfer (TT) experiences and analyses the motivations behind the enabling agreements. TT is defined as the dissemination of knowledge and expertise from developed country organisations to developing country organisations.
• Document

  The effect of changing intellectual property on pharmaceutical industry prospects in India and China: considerations for access to medicines

  Department for International Development Health Systems Resource Centre, 2004

  This HSRC report explores the implications of changing Intellectual Property (IP) on access to medicines (ATM) in India and China by asking two key questions: how will the implementation of product patents affect the pharmaceutical industries in these countries; and what will happen to the supply of low-priced medicines domestically and internationally.
• Document

  Processes and issues for improving access to medicines: willingness and ability to utilise TRIPS flexibilities in non-producing countries

  Department for International Development Health Systems Resource Centre, 2004

  This HSRC paper examines ways in which a non-producing country (NPD) can utilise TRIPS flexibilities, primarily focusing on importation. It also examines how to promote local production through pharmaceutical capacity building and through both compulsory and voluntary licensing.
• Document

  Women's reasons for not participating in follow up visits before starting short course antiretroviral prophylaxis for prevention of mother to child transmission of HIV: qualitative interview study

  British Medical Journal, 2004

  This publication aims find out why pregnant women attending a public antenatal clinic in Abidjan, Côte d'Ivoire do not participate in necessary follow up visits before starting antiretroviral prophylaxis.
• Document

  Manual for reducing drug-related harm in Asia

  Centre for Harm Reduction, Melbourne, 2003

  This updated edition of the 1999 manual from The Centre for Harm Reduction provides a comprehensive guide to HIV/AIDS programming for injecting drug users (IDUs) in Asia. Following an overview of the HIV epidemic among IDUs in Asia, the manual details the rationale for harm reduction, and examines how this can be balanced and integrated with supply and demand reduction approaches.
• Document

  Patents, access to medicines and the role of non-governmental organisations

  Médecins Sans Frontières, 2004

  This Médecins Sans Frontières (MSF) paper looks at how patents adversely affect access to affordable medicines. Although effective medicine is available to treat many global diseases, one-third of the world’s population lacks access to these basic, but expensive drugs as a result of patent rights.
• Document

  Reproductive health interventions: which ones work and what do they cost?

  Policy Project, Futures Group, Washington, 2000

  This paper, produced by the POLICY project, looks at the effectiveness and cost of different reproductive health care interventions, and asks what criteria governments can use to decide whether they will provide certain interventions.
• Document

  HIV/AIDS and TB in Central Asia: country profiles

  World Bank, 2004

  This report, published by the World Bank, looks at the growth of TB and HIV in Central Asia. It emphasises that although HIV levels in the region are currently low, policy makers urgently need to develop strategies for addressing the projected epidemic, based on international evidence on the growth of HIV infection.
• Document

  The ICPD at ten

  World Health Organization, 2003

  Ten years after the International Conference on Population and Development (ICPD) was held in Cairo, this issue of Entre Nous magazine, published by the WHO Regional Office for Europe, reviews progress made in implementing the programme of action adopted at the conference.
• Document

  25 years of essential medicines progress

  Essential Drugs and Medicine Policy, WHO, 2003

  The historic first meeting of the World Health Organization (WHO) Expert Committee on the Selection of Essential Drugs took place in Geneva in 1977. Today, more than 150 countries have adopted the concept and developed their own national lists of essential medicines.This special issue of the Essential Drugs Monitor, produced by the WHO, celebrates 25 years of the essential medicines concept.

Pages